BCL11A, MLLT3, ZNF521, PHC1, and PCGF3 also showed subtype-specific dysregulation in breast cancers; BCL11A, ZNF521, and PHC1 were specifically downregulated in luminal subtype cancers relative to their matched normal tissue. Here, PCGF3 is linked to cancer.